JUL 19, 2019 11:11 AM PDT

Possible Non-Hormonal Treatment For Endometriosis On Horizon

WRITTEN BY: Abbie Arce

With over 200,000 cases reported annually, endometriosis is a big concern in women’s health. Scientists don’t yet know what causes the painful disorder. It is characterized by the abnormal growth of the endometrium outside the uterus. The endometrium bleeds and is shed each month during menstruation. Endometrial tissues outside the uterus behave in the same way. This tissue and blood then have no place to exit the body. 

The tissue surrounding the misplaced endometrium can become irritated, which can eventually lead to scarring. Scarring and adhesions can, over time, cause pelvic tissue and organs to stick together. If the condition has spread to involve the ovaries, an ovarian cyst may form. In addition to severe pain, this condition is the most common cause of infertility in women.

The diagnosis of endometriosis generally includes a series of questions from the doctor. Doctors may ask about the location of your pain and when it occurs. Tests typically include a pelvic exam in which the doctor manually feels for cysts. An ultrasound, MRI, or laparoscopy may also be used to view inside the body for a more detailed analysis. While imaging tests are more common, the more-invasive laparoscopy is most often used in surgical planning to give detailed information to a surgeon about the extent of the condition.

Treatment for endometriosis generally focuses on hormonal methods. These can cause adverse side effects like fertility suppression and therefore are not ideal. Additionally, surgery to remove endometrial implants or even the entire uterus with ovaries are considered, but again not ideal.

New research has found that macrophages play a central role in the development of endometrial growths. Though they intend to protect the body, macrophages are altered by exposure to the disease environment. These immune cells, once altered, help to develop the blood supply for endometrial growth. They also help stimulate the growth of nerve cells in the area through the release of IGF-1. 

The research suggests that blocking the release of IGF-1 from disease-modified macrophages may help prevent the body from supporting these abnormal growths, and provide a non-hormonal form of relief for the condition.

 

Sources: World Endometriosis Research Foundation, TEDFASEB

About the Author
  • Abbie is an AFAA certified personal trainer and fitness instructor with an interest in all things health-science. She has recently graduated with her BS in Applied Sport and Exercise Science from Barry University in Miami. Next, she intends to earn an MPH with a focus in Epidemiology.
You May Also Like
AUG 05, 2020
Cancer
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
AUG 05, 2020
A New Test to Analyze Cell-Free DNA in Cancer Diagnostics
Cell-free DNA (cfDNA) are small pieces of genomic DNA that have escaped into the bloodstream either through active relea ...
AUG 15, 2020
Cardiology
Following Platelets to Diagnose Myocarditis
AUG 15, 2020
Following Platelets to Diagnose Myocarditis
The heart is a sensitive thing, prone not just to metaphorical heartbreak, but genuine issues if not taken care of. Myoc ...
AUG 20, 2020
Cardiology
A New Test to Discern Kawasaki Disease from Sepsis
AUG 20, 2020
A New Test to Discern Kawasaki Disease from Sepsis
Kawasaki disease is a rare cardiovascular disease affecting children under the age of five. If untreated, there is a cha ...
SEP 07, 2020
Cell & Molecular Biology
With Nanopores, Small Samples Detect Diseases
SEP 07, 2020
With Nanopores, Small Samples Detect Diseases
If you've ever been through a battery of tests while doctors try to find a diagnosis for an ailment, you know that many ...
SEP 25, 2020
Clinical & Molecular DX
Ray of Hope: Rare Cancer Biomarker Discovered
SEP 25, 2020
Ray of Hope: Rare Cancer Biomarker Discovered
Biliary tract cancer, or BTC, isn’t as talked about as breast or prostate cancers, probably because its incidence ...
OCT 13, 2020
Cardiology
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
OCT 13, 2020
A Kidney Toxin Could Act as a Biomarker for Cardiovascular Risk
Biomarkers have taken the diagnostic field by storm over the past decade. The search for stable, easy to access indicato ...
Loading Comments...